STAAR Surgical Company
STAANASDAQHealthcare● Active
$29.96
$-0.03(-0.10%)
Market Cap$1.5B
P/E Ratio—
52W High$35.87
52W Low$15.59
STAAR Surgical Company (STAA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · STAA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-01 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.24B | $0.31B | $0.32B | $0.28B | $0.23B |
| Cost of Revenue | $0.06B | $0.07B | $0.07B | $0.06B | $0.05B |
| Gross Profit | $0.18B | $0.24B | $0.25B | $0.22B | $0.18B |
| Gross Margin %(computed) | 76.19% | 76.32% | 78.36% | 78.55% | 77.51% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.05B | $0.04B | $0.04B | $0.03B |
| G&A Expenses | $0.09B | $0.09B | $0.07B | $0.05B | $0.04B |
| Total Operating Expenses | $0.23B | $0.25B | $0.22B | $0.18B | $0.15B |
| Operating Income | ($0.05B) | ($0.01B) | $0.03B | $0.04B | $0.03B |
| Operating Margin %(computed) | -19.19% | -4.02% | 8.71% | 15.40% | 14.47% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | — |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.01B) | $0.03B | $0.05B | $0.03B |
| Income Tax Expense | ($0.00B) | $0.01B | $0.01B | $0.01B | $0.00B |
| Net Income | ($0.08B) | ($0.02B) | $0.02B | $0.04B | $0.03B |
| Net Margin %(computed) | -33.60% | -6.44% | 6.62% | 13.95% | 11.94% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.62 | $-0.41 | $0.44 | $0.83 | $0.52 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| EBITDA | ($0.04B) | ($0.01B) | $0.03B | $0.05B | $0.04B |
| EBITDA Margin %(computed) | -15.54% | -1.82% | 10.30% | 16.99% | 16.05% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more STAAR Surgical Company data
About STAAR Surgical Company (STAA) Income Statement
STAAR Surgical Company (STAA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, STAA reported revenue of $0.24B, gross profit of $0.18B (gross margin 76.19%), and net income of ($0.08B) — a net profit margin of -33.60%.
Frequently asked questions
STAA · 4 questionsSTAAR Surgical Company (STAA) reported revenue of $0.24B for 2026, down 23.7% year-over-year.
STAA revenueSTAA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08